US 11377502
Anti-MSR1 antibodies and methods of use thereof
granted A61KA61K2039/505A61K31/165
Quick answer
US patent 11377502 (Anti-MSR1 antibodies and methods of use thereof) held by REGENERON PHARMACEUTICALS, INC. expires Mon Jun 30 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Jul 05 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 30 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 5
- CPC classes
- A61K, A61K2039/505, A61K31/165, A61K31/167, A61K31/417